<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>CytoCares | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-16T20:16:12+08:00</updated>
  <subtitle>为您传递细胞治疗相关行业信息与技术进展，共同促进国内免疫治疗技术发展与行业繁荣</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>IL-8促进肿瘤发展，免疫治疗新靶点</title>
    <updated>2020-11-16T19:07:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/sozL8cj1Ix3yYldW-hERKA</id>
    <link href="https://mp.weixin.qq.com/s/sozL8cj1Ix3yYldW-hERKA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>本周｜八大门派赴医药江湖，BiG六载凭实力出圈！</title>
    <updated>2020-11-16T19:07:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/N_G3cB8Q9awWOfaLijWwng</id>
    <link href="https://mp.weixin.qq.com/s/N_G3cB8Q9awWOfaLijWwng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从TME到I/O，亦正亦邪的TGF-β！</title>
    <updated>2020-11-13T19:27:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/gk7XgB2FnvUn-PjTjjYz2g</id>
    <link href="https://mp.weixin.qq.com/s/gk7XgB2FnvUn-PjTjjYz2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗体偶联药物国内研发现状及企业布局分析</title>
    <updated>2020-11-12T18:50:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/4Mfeku7-6XbLWgS3UsTD4A</id>
    <link href="https://mp.weixin.qq.com/s/4Mfeku7-6XbLWgS3UsTD4A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗体药物动态-11月12日</title>
    <updated>2020-11-12T18:50:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/qUEKcl0fyoBmTCqyU55gjQ</id>
    <link href="https://mp.weixin.qq.com/s/qUEKcl0fyoBmTCqyU55gjQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NK细胞抗癌四阶段及药物开发</title>
    <updated>2020-11-11T18:59:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/IpqZlmnTSNsNMFaZ8kBolw</id>
    <link href="https://mp.weixin.qq.com/s/IpqZlmnTSNsNMFaZ8kBolw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗体药物动态-11月11日</title>
    <updated>2020-11-11T18:59:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/pxAD658j9429m5-o81mcbA</id>
    <link href="https://mp.weixin.qq.com/s/pxAD658j9429m5-o81mcbA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤浸润淋巴细胞（TILs）-TCR工程改造</title>
    <updated>2020-11-10T19:11:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/cQHDkb3ZVpibu34bQJI4dA</id>
    <link href="https://mp.weixin.qq.com/s/cQHDkb3ZVpibu34bQJI4dA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗体药物动态-11月10日</title>
    <updated>2020-11-10T19:11:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/jg7LNneGVzbnz_QMDPTwMQ</id>
    <link href="https://mp.weixin.qq.com/s/jg7LNneGVzbnz_QMDPTwMQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>飞速五年！中国CAR-T临床试验概况</title>
    <updated>2020-11-06T20:54:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/VG_tZopfLUQ6RSK30jzk4Q</id>
    <link href="https://mp.weixin.qq.com/s/VG_tZopfLUQ6RSK30jzk4Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗体药物动态-11月6日</title>
    <updated>2020-11-06T20:54:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/3nFq3nfFd7IQzCsbDIE23g</id>
    <link href="https://mp.weixin.qq.com/s/3nFq3nfFd7IQzCsbDIE23g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗体药物动态-11月5日</title>
    <updated>2020-11-05T19:24:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/6fqUSBpm-Memzs-4144JkA</id>
    <link href="https://mp.weixin.qq.com/s/6fqUSBpm-Memzs-4144JkA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>下一代肿瘤免疫药物：肿瘤免疫治疗当前的趋势转变</title>
    <updated>2020-11-04T18:46:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/Trw9bcJgZg-Ern7f8fdhOA</id>
    <link href="https://mp.weixin.qq.com/s/Trw9bcJgZg-Ern7f8fdhOA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗体药物动态-11月4日</title>
    <updated>2020-11-04T18:46:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/LrkoJdPcBiTxNpWKgH0wAA</id>
    <link href="https://mp.weixin.qq.com/s/LrkoJdPcBiTxNpWKgH0wAA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>单克隆抗体技术简史及经典药物</title>
    <updated>2020-11-02T18:53:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/1Iyt4bVZ-5ntEuosHp9U0g</id>
    <link href="https://mp.weixin.qq.com/s/1Iyt4bVZ-5ntEuosHp9U0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>转座子系统在CAR-T中的应用</title>
    <updated>2020-10-29T18:50:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/iFy_tb8-eU1aBdhflM2CEQ</id>
    <link href="https://mp.weixin.qq.com/s/iFy_tb8-eU1aBdhflM2CEQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗体药物动态-10月29日</title>
    <updated>2020-10-29T18:50:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/q-B25q1iVx_3TpKlaEKhug</id>
    <link href="https://mp.weixin.qq.com/s/q-B25q1iVx_3TpKlaEKhug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>